347 related articles for article (PubMed ID: 17172648)
1. TH2 cells in the pathogenesis of airway remodeling: regulatory T cells a plausible panacea for asthma.
McGee HS; Agrawal DK
Immunol Res; 2006; 35(3):219-32. PubMed ID: 17172648
[TBL] [Abstract][Full Text] [Related]
2. CD4+ Th2 cells function alike effector Tr1 and Th1 cells through the deletion of a single cytokine IL-6 and IL-10 gene.
Ankathatti Munegowda M; Xu S; Freywald A; Xiang J
Mol Immunol; 2012 Jun; 51(2):143-9. PubMed ID: 22424785
[TBL] [Abstract][Full Text] [Related]
3. Naturally occurring and inducible T-regulatory cells modulating immune response in allergic asthma.
McGee HS; Agrawal DK
Am J Respir Crit Care Med; 2009 Aug; 180(3):211-25. PubMed ID: 19447898
[TBL] [Abstract][Full Text] [Related]
4. Tolerogenic dendritic cells induce CD4+CD25hiFoxp3+ regulatory T cell differentiation from CD4+CD25-/loFoxp3- effector T cells.
Huang H; Dawicki W; Zhang X; Town J; Gordon JR
J Immunol; 2010 Nov; 185(9):5003-10. PubMed ID: 20870943
[TBL] [Abstract][Full Text] [Related]
5. Regulatory T cells and asthma.
Robinson DS
Clin Exp Allergy; 2009 Sep; 39(9):1314-23. PubMed ID: 19538496
[TBL] [Abstract][Full Text] [Related]
6. Expression of IL-37 contributes to the immunosuppressive property of human CD4+CD25+ regulatory T cells.
Shuai X; Wei-min L; Tong YL; Dong N; Sheng ZY; Yao YM
Sci Rep; 2015 Sep; 5():14478. PubMed ID: 26411375
[TBL] [Abstract][Full Text] [Related]
7. Stimulation of α7 nicotinic acetylcholine receptor by nicotine increases suppressive capacity of naturally occurring CD4+CD25+ regulatory T cells in mice in vitro.
Wang DW; Zhou RB; Yao YM; Zhu XM; Yin YM; Zhao GJ; Dong N; Sheng ZY
J Pharmacol Exp Ther; 2010 Dec; 335(3):553-61. PubMed ID: 20843956
[TBL] [Abstract][Full Text] [Related]
8. Expression of tumor necrosis factor-α induced protein 8 like-2 contributes to the immunosuppressive property of CD4(+)CD25(+) regulatory T cells in mice.
Luan YY; Yao YM; Zhang L; Dong N; Zhang QH; Yu Y; Sheng ZY
Mol Immunol; 2011 Oct; 49(1-2):219-26. PubMed ID: 21963221
[TBL] [Abstract][Full Text] [Related]
9. The potential effect and mechanism of high-mobility group box 1 protein on regulatory T cell-mediated immunosuppression.
Zhang Y; Yao YM; Huang LF; Dong N; Yu Y; Sheng ZY
J Interferon Cytokine Res; 2011 Feb; 31(2):249-57. PubMed ID: 21087077
[TBL] [Abstract][Full Text] [Related]
10. CD4(+) CD25(low) GITR(+) cells: a novel human CD4(+) T-cell population with regulatory activity.
Bianchini R; Bistoni O; Alunno A; Petrillo MG; Ronchetti S; Sportoletti P; Bocci EB; Nocentini G; Gerli R; Riccardi C
Eur J Immunol; 2011 Aug; 41(8):2269-78. PubMed ID: 21557210
[TBL] [Abstract][Full Text] [Related]
11. Identification of tonsillar CD4
Sumitomo S; Nakachi S; Okamura T; Tsuchida Y; Kato R; Shoda H; Furukawa A; Kitahara N; Kondo K; Yamasoba T; Yamamoto K; Fujio K
J Autoimmun; 2017 Jan; 76():75-84. PubMed ID: 27653378
[TBL] [Abstract][Full Text] [Related]
12. Birch pollen immunotherapy leads to differential induction of regulatory T cells and delayed helper T cell immune deviation.
Möbs C; Slotosch C; Löffler H; Jakob T; Hertl M; Pfützner W
J Immunol; 2010 Feb; 184(4):2194-203. PubMed ID: 20048125
[TBL] [Abstract][Full Text] [Related]
13. Activation of the aryl hydrocarbon receptor reduces the number of precursor and effector T cells, but preserves thymic CD4+CD25+Foxp3+ regulatory T cells.
Schulz VJ; Smit JJ; Bol-Schoenmakers M; van Duursen MB; van den Berg M; Pieters RH
Toxicol Lett; 2012 Nov; 215(2):100-9. PubMed ID: 23041608
[TBL] [Abstract][Full Text] [Related]
14. CD4+CD25+ T cells alloactivated ex vivo by IL-2 or IL-4 become potent alloantigen-specific inhibitors of rejection with different phenotypes, suggesting separate pathways of activation by Th1 and Th2 responses.
Verma ND; Plain KM; Nomura M; Tran GT; Robinson C; Boyd R; Hodgkinson SJ; Hall BM
Blood; 2009 Jan; 113(2):479-87. PubMed ID: 18827184
[TBL] [Abstract][Full Text] [Related]
15. Thymic regulatory T cells.
Maggi E; Cosmi L; Liotta F; Romagnani P; Romagnani S; Annunziato F
Autoimmun Rev; 2005 Nov; 4(8):579-86. PubMed ID: 16214099
[TBL] [Abstract][Full Text] [Related]
16. Thymic and Postthymic Regulation of Naïve CD4(+) T-Cell Lineage Fates in Humans and Mice Models.
Belizário JE; Brandão W; Rossato C; Peron JP
Mediators Inflamm; 2016; 2016():9523628. PubMed ID: 27313405
[TBL] [Abstract][Full Text] [Related]
17. Phenotype alterations in regulatory T-cell subsets in primary HIV infection and identification of Tr1-like cells as the main interleukin 10-producing CD4+ T cells.
Chevalier MF; Didier C; Petitjean G; Karmochkine M; Girard PM; Barré-Sinoussi F; Scott-Algara D; Weiss L
J Infect Dis; 2015 Mar; 211(5):769-79. PubMed ID: 25281758
[TBL] [Abstract][Full Text] [Related]
18. Expression of ICOS on human melanoma-infiltrating CD4+CD25highFoxp3+ T regulatory cells: implications and impact on tumor-mediated immune suppression.
Strauss L; Bergmann C; Szczepanski MJ; Lang S; Kirkwood JM; Whiteside TL
J Immunol; 2008 Mar; 180(5):2967-80. PubMed ID: 18292519
[TBL] [Abstract][Full Text] [Related]
19. Inducible and naturally occurring regulatory T cells enhance lung allergic responses through divergent transcriptional pathways.
Joetham A; Schedel M; O'Connor BP; Kim S; Takeda K; Abbott J; Gelfand EW
J Allergy Clin Immunol; 2017 Apr; 139(4):1331-1342. PubMed ID: 27542981
[TBL] [Abstract][Full Text] [Related]
20. Alloantigen specific T regulatory cells in transplant tolerance.
Hall BM; Tran G; Hodgkinson SJ
Int Immunopharmacol; 2009 May; 9(5):570-4. PubMed ID: 19539571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]